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Background
Families express a need for information to support people with
severe anorexia nervosa.
Aims
To examine the impact of the addition of a skills training
intervention for caregivers (Experienced Caregivers Helping
Others, ECHO) to standard care.
Method
Patients over the age of 12 (mean age 26 years, duration
72 months illness) with a primary diagnosis of anorexia nervosa
and their caregivers were recruited from 15 in-patient services
in the UK. Families were randomised to ECHO (a book, DVDs
and five coaching sessions per caregiver) or treatment as
usual. Patient (n=178) and caregiver (n=268) outcomes were
measured at discharge and 6 and 12 months after discharge.
Results
Patients with caregivers in the ECHO group had reduced eating
disorder psychopathology (EDE-Q) and improved quality of life
(WHO-Quol; both effects small) and reduced in-patient bed
days (7–12 months post-discharge). Caregivers in the ECHO
group had reduced burden (Eating Disorder Symptom Impact
Scale, EDSIS), expressed emotion (Family Questionnaire, FQ)
and time spent caregiving at 6 months but these effects were
diminished at 12 months.
Conclusions
Small but sustained improvements in symptoms and bed use
are seen in the intervention group. Moreover, caregivers were
less burdened and spent less time providing care. Caregivers
had most benefit at 6 months suggesting that booster sessions,
perhaps jointly with the patients, may be needed to maintain
the effect. Sharing skills and information with caregivers may
be an effective way to improve outcomes. This randomised
controlled trial (RCT) was registered with Current Controlled
Trials ISRCTN06149665.
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Anorexia nervosa usually develops in early adolescence but over
50% of cases have an illness that persists for over 7 years and
extends into adulthood.1 The treatment response differs according
to the stage of illness.2 For example, family-based therapy is more
effective in the early stage of illness.3 The absolute rate of full
recovery is less than one-third overtime.4,5
Individuals with high levels of medical risk are managed by
specialised in-patient care. The mortality, morbidity and service
use and cost for in-patient care for anorexia nervosa are amongst
the highest of all psychiatric disorders.6–8 Protracted support from
both the state and/or family is needed for people with the severe
enduring form of illness.9 Family members experience high levels
of burden and distress10,11 and request information and help with
their caregiving role.12–14 We have developed a skills training
intervention (Experienced Caregivers Helping Others (ECHO)) to
support the caregiving role at home based on caregivers’ needs
and our cognitive interpersonal model of anorexia nervosa.15,16
The aim of this study was to evaluate the impact of the addition
of the ECHO intervention on patient and caregivers well-being
following in-patient care. Families were randomised to receive ECHO
plus treatment as usual (TAU) or TAU alone at the time patients
were admitted to hospital. Caregiver and patient well-being was
followed in the year following discharge. The trial investigated the
following hypotheses regarding patient (P) and caregiver (C) out-
comes. The primary patient hypothesis was that at 12-month follow-
up, patients with caregivers allocated to ECHO would have a reduced
rate of relapse compared to those allocated to TAU. The secondary
hypothesis for patients was that patients with caregivers allocated
to ECHO would sustain a higher body mass index (BMI) and
quality of life and lower eating psychopathology (EDE-Q) and
distress (Depression, Anxiety and Stress Scale-21 (DASS-21)) post-
randomisation compared to those allocated to TAU. The primary
hypothesis for caregivers was that caregivers allocated to ECHO
would have less distress (depression, anxiety and stress DASS) in the
year after discharge compared to those allocated to TAU. The sec‐
ondary hypothesis for caregivers was that those who receive ECHO
will report lower expressed emotion, accommodation and enabling,
caregiving burden, time spent caregiving and improved quality of life
post-randomisation compared to those allocated to TAU.
Method
This was a pragmatic, two-arm, multicentre parallel group
randomised controlled trial (RCT). A detailed account of the trial
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protocol, including the description of the ECHO caregiver
intervention, has been published.17 Consenting caregivers of
patients who met eligibility criteria were randomly allocated to
receive either ECHO (in addition to treatment as usual (TAU)) or
TAU only. Guidance for the ECHO intervention was delivered by
‘experienced’ coaches (people with lived experience of eating
disorders, n=15) and also (in order to have a sufficient numbers)
post-graduate-level psychologists (without clinical training, n=5)
who were specifically trained and supervised. Patients and their
caregivers were recruited from 15 hospital units providing
National Health Service (NHS) in-patient/day-patient care for
people with eating disorders. Outcome measures were collected at
baseline, discharge, and 6 and 12 months following discharge.
Ethics approval was granted by the Royal Free Hospital Ethics
Committee (08/H0720/41) with site-specific ethics and govern-
ance approval for all participating sites. The study was adopted
by the Mental Health Research Network (MHRN). Following
informed consent (from caregiver and patient) and completion of
baseline assessment (on admission to the treatment facility),
caregivers of a patient were randomly allocated to ECHO or
TAU using an online system. Randomisation was carried out
independently by the King’s Clinical Trials Unit at King’s
College London and employed minimisation with stratification
factors, study site (n=15) and disease severity (binary with the
‘severe’ category defined as one or both of body mass index
(BMI) <15, presence of compensatory vomiting). The statisti-
cians were masked to treatment allocation until adherence was
measured.
Setting, recruitment and participants
Fourteen of the sites were eating disorder specialist in-patient
wards in the UK (13 adults, 1 adolescent); one was a general
(adolescent) psychiatric ward with eating disorder specialist staff.
Four sites recruited day-patients as well as in-patients into the
study. One of the specialist sites made local referrals to specialist
eating disorder in-patient wards in the UK. Clinical Studies
Officers (CSOs) from the MHRN supported recruitment of patients.
Inclusion criteria: patients meeting the criteria of DSM-IV anorexia
nervosa aged 12 years or above, able to speak and understand
English. Exclusion criteria: no identified caregiver, patient/caregivers
taking part in another treatment study or discharged from their
in-patient stay before baseline assessment completed. In addition,
participants with a severe comorbidity at time of admission
(e.g. severe intellectual disability, physical illness, and psychosis)
were not included in the study.
Interventions
Correspondence with caregivers on the randomisation outcome
was by post. The ECHO group had a letter explaining that they
would be contacted by their telephone coach and supporting
documentation was sent (action/goal sheets, staging based on the
transtheoretical model of change,18 frequently asked questions and
troubleshooting for technical support). Those allocated to the
TAU arm were given contact details for Beat, the leading UK
eating disorder charity, and were offered access to the intervention
on completion.
ECHO
Participants allocated to ECHO received this intervention as
an addition to TAU. The materials were sent and the coaching
begun immediately after randomisation. ECHO uses a skills
training approach and consists of a book19 and five DVDs
(three theoretical, two practical). The DVDs complement the
information presented in the book with role plays and practical
examples in using a motivational interviewing style of commu-
nication and strategies to reduce expressed emotion and accom-
modation. The information on the DVDs is presented visually
with audio voiceover. A more detailed description of DVD
content and the coaching input is described elsewhere.17,20
(A professionally produced version is available through the charity
Succeed – www.succeedfoundation.org.)
In addition to the book and DVDs, the intervention package
included five telephone coaching sessions per caregiver (up to 10
per family, e.g. mother and father). Single caregivers could receive
up to 10 coaching calls. Participants were contacted by the coach
within 2 weeks of receiving the material by post. Calls (of up
to 40 min) were made by appointment approximately two weekly.
To be classified as completing the intervention a minimum of four
calls (per family) were delivered or 75% of the book read.
Information on coaches, their training and measurement of
quality assurance is described in the published protocol.17 The
majority of coaches (64%) attained the recommended skill level
for motivational interviewing.21
Treatment as usual
In-patient or day-patient treatment
The National Institute for Health and Care Excellence (NICE)
guidelines have several Grade C recommendations about in-
patient care.22 The Royal College of Psychiatrists has developed
accreditation standards which detail how caregivers should be
involved in in-patient treatment.23 For this study, day-patients
were defined as patients who required non-residential intensive
specialist treatment (≥4 days a week).
Aftercare
The NICE guidelines specify that aftercare (focusing on eating
behaviour) is provided for a year after discharge. This typically
includes monitoring of physical risks, dietetic assessment and advice
and some form of individual out-patient therapy. Cognitive–
behavioural therapy, interpersonal psychotherapy or focal psycho-
dynamic therapy are most commonly offered (see Results section for
more detail).
Assessment measures
All participants (patients and caregivers) completed self-report
assessments by post/telephone on admission to treatment unit,
discharge from hospital and thereafter at 6 -and 12-month time
point’s post-discharge. For the year following discharge, patients
additionally completed a short monthly assessment on core eating
symptoms by telephone, email or post. Patient and caregiver
primary and secondary outcomes are listed below. All measures
have been validated in eating disorder populations and have good
psychometric properties. See published protocol for more
details.17
Patients’ assessment measures
Patients’ baseline assessment includes the following:
. Sociodemographic features (a checklist used in pilot
studies).
Patients’ clinical outcome measures include the following:
. BMI (from clinical measures of height and weight).
. Eating Disorder Examination Questionnaire (EDE-Q).24
A self-report measure of eating disorder symptoms with
good reliability and validity.
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. Depression, Anxiety and Stress Scale (DASS-21).25 A
21-item self-report measure validated in both clinical
and non-clinical samples with good internal reliability.
. World Health Organization – Quality of Life Question-
naire (WHO-Quol).26 A self-report measure with good
validity.
. The Client Service Receipt Inventory (CSRI);27 structured
interview measuring use of specialist and generic health
services.
Caregivers’ assessment measures include the following:
. Burden: Eating Disorder Symptom Impact Scale
(EDSIS):28 A 24-item self-report measure.
. DASS. As described above.
. Accommodation and Enabling Scale for Eating Disor-
ders.29 A 33-item self-report measure.
. Family Questionnaire (FQ): this is a 20-item self-report
measure assessing expressed emotion in caregivers using a
4-point Likert scale.30
. WHO-Quol.26
. The CSRI;27 As above but caregiver version measuring
time spent caregiving.
Statistical analysis
All statistical analyses were based on the intention-to-treat
principle; participants were analysed in the treatment arm to
which they were randomised. The primary patient clinical out-
come was time from discharge to relapse. A linear change was
assumed between monthly measurements of BMI in order to
interpolate the day on which two points were estimated to be lost.
This variable was right censored since relapse might not have
occurred by the end of the study period (1 year) or follow-up
data for BMI could be missing. If five consecutive BMI
measurements were missed, time to relapse was considered
censored. The primary caregiver clinical outcome was distress
at 12 months after discharge. To account for two primary
outcomes, group differences on these outcomes were tested at a
significance level of 2.5%. Secondary caregiver and patient
outcomes were continuous measures at discharge, 6-month or
1-year follow-up.
Time to relapse was defined as readmission to hospital due to
their eating disorder or a drop of two points from discharge in
BMI measured on a monthly basis (whichever came first) and
analysed using Cox regression. Explanatory variables in this model
were the variable of interest (treatment arm) and randomisation
stratifiers (site and illness severity categories). The effect of
treatment was estimated by the hazard ratio of relapse comparing
ECHO with TAU.
The continuous secondary patient outcomes were analysed
using linear mixed models. The dependent variable was the
outcome at the respective time point (e.g. BMI at 12-month
post-discharge) and (fixed) explanatory variables were given by
treatment arm, baseline values of the variable under investigation
(e.g. BMI at pre-randomisation) and randomisation stratifiers.
In addition, the models can contain random intercepts for
coaches in the ECHO group to allow for correlation in outcomes
due to treatment being facilitated by the same coach. The
models were used to estimate differences between treatment
arms at each time point. Standardised treatment effect estimates
were calculated by dividing estimated group differences by the
common pre-randomisation standard deviation of the respective
outcome.
Outcome variables contained considerable numbers of missing
values; see Results section for details. We empirically identified a
number of baseline variables that were predictive of missing values
in outcome and also found that the primary caregiver not
adhering to ECHO (coded ‘1’=completed at least four coaching
sessions or read at least 75% the coaching manual, ‘0’=did not
complete the intervention) was predictive of loss-to-follow up; see
Results section for details. To allow for these processes driving
missingness, in addition to allowing randomised group and values
of the outcome under investigation at different time points being
predictive of missingness, multiple imputation (MI), using
chained equations31 with 100 imputations, was implemented.
This allowed us to include predictors of missingness (including
the post-randomisation variable adherence) in the imputation step
without having to condition on these variables in the analyses
models.32
The analyses for continuous caregiver outcomes needed to
encompass up to two caregivers per family (a nominated primary
and second caregiver). Therefore, the analysis and imputation
models described for patients were extended. First, the analysis
models contained an additional random intercept that varied
at the level of the patient to allow for similar outcomes for
caregivers of the same patient. Second, to ensure that correla-
tions were also reflected in the imputed values, imputations were
carried out at the level of the patient allowing for two outcome
variables – one for the primary caregiver and another for
secondary caregiver (set to missing when there was no second
caregiver, with resulting imputed values discarded before
analysis).
Statistical analyses were carried out in Stata version 11. The
user-contributed command ice was used for MI.31
Results
Participant flow
This study represents a collaboration of major UK eating disorder
treatment centres and describes a large cross-section of severely ill
patients with anorexia nervosa (37% had regular objective binging
and 30% had regular vomiting). In total, 178 patients and 268
caregivers were recruited. The CONSORT diagram for the study is
shown in Fig. 1.
Sample characteristics
As expected from randomisation, patient and caregiver character-
istics were well-balanced across groups (Table 1).
Patients
The descriptive details of the sample and the short-term effects of
hospital treatment comparing symptom levels on admission and
on discharge from in-patient care have been published.33
The majority of the patient group (n=178) was significantly
underweight (BMI <15 kg/m2) or had medical instability because
of electrolyte problems. The mean age was 26 (s.d.=9) years.
Eleven cases were from adolescent units; these were approximately
equally distributed between the interventions (Table 1). The
majority of cases (n=123, 69%) had an illness duration of more
than 3 years and 47% (n=83) exceeding 6 years (enduring
anorexia nervosa). Of the 11 adolescents: 8 had illness duration
<3 years and 2 had illness duration >3 years. (This item was
missing on one adolescent.) The median duration of the admis-
sion was 153.5 days (range 28–991). One patient remained an in-
patient throughout the 2 years of the study.
Hibbs et al
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Patients
Primary outcome (BMI) (n=60) (65%)
Lost to follow-up (n=4) 
Carers
Primary outcome (DASS) (n=91) (68%)
Lost to follow-up (n=1)
Patients
Primary outcome (BMI) (n=52) (60%)
Lost to follow-up (n=13) 
Carers
Primary outcome (DASS) (n=91) (68%) 
Lost to follow-up (n=1)
Assessed for eligibility (n=599)
Patients
Primary outcome (BMI) (n=64) (70%)
Lost to follow-up (n=16) 
Carers
Primary outcome (DASS) (n=92) (69%)
Lost to follow-up (n= 7)
Patients
Primary outcome (BMI) (n=80) (87%)
Lost to follow-up (n=12)
Carers
Primary outcome (DASS) (n=99) (74%)
Lost to follow-up (n=35)
Allocated to TAU
Patients (n=92)
Carers (n=134)
Patients
Primary outcome (BMI) (n=82) (95%)
Lost to follow-up (n=4)
Carers
Primary outcome (DASS) (n=93) (69%)
Lost to follow-up (n=41)
Allocated to intervention
Patients (n=86)
Carers (n=134)
Patients
Primary outcome (BMI) (n=65) (76%)
Lost to follow-up (n=17)
Carers
Primary outcome (DASS) (n=92) (69%)
Lost to follow-up (n=1)
Allocation
6-month follow-up
Discharge
Families randomised (n=178)  
PATIENT: Excluded (n=346)
Not meeting inclusion criteria (n=93)
Declined to participate (n=252)
Other reasons (n=1)Enrolment
Patient consent (n=266)
Carers approached (n=476)
CARER: Excluded (n=214)
Not meeting inclusion criteria (n=2)
Declined to participate (n=212)
PATIENT: Excluded (n= 69)
Carers declined to take part (n=69)
Carer consent (n=262)
12-month follow-up
Fig. 1 Study consort diagram showing participant recruitment, allocation to TAU or TAU augmented with the ECHO intervention. TAU, treatment as
usual; BMI, body mass index; DASS, Depression, Anxiety and Stress Scale.
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Caregivers
A total of 268 caregivers (178 primary caregivers, 90 secondary
caregivers) were recruited (all were adults: 144 mothers, 81 fathers,
28 partners, 7 siblings, 5 friends, 3 other relatives). The mean
number of caregivers per participant was 1.47 (range 1–3); see
Table 1 for the number of caregivers involved in each group. The
majority (69%) lived with the patient with greater than 21 h of
face-to-face contact time per week in 48% cases.
Table 1 Baseline characteristics by treatment group
ECHO Treatment as usual
Patient (n = 86) Carer (n = 134) Patient (n = 92) Carer (n = 134)
Demographics
Age, years: median (range) 23.16 (12.52–62.72) 52.22 (22.22–78.54) 24.34 (13.73–57.31) 53.18 (19.70–78.88)
Female, n (%) 83 (97) 80 (60) 86 (93) 81 (60)
Ethnic origin, n (%)
White (British, Irish, other) 80 (93) 125 (93) 81 (88) 125 (93)
Asian/mixed/other 5 (6) 6 (4) 5 (6) 5 (4)
Missing 1 (1) 3 (2) 6 (7) 4 (3)
Employment, n (%)
Full-time employed 8 (9) 54 (40) 8 (9) 60 (45)
Part-time employed 4 (5) 29 (22) 6 (7) 25 (19)
Homemaker/unemployed/sick/retired/other 48 (56) 46 (34) 47 (51) 44 (33)
Student 25 (29) 4 (3) 28 (30) 1 (1)
Missing 1 (1) 1 (1) 3 (3) 4 (3)
Highest level of education, n (%)
No qualification 4 (5) 11 (8) 5 (5) 9 (7)
O/A Levels 40 (47) 51 (38) 49 (53) 37 (28)
University/higher degrees 40 (47) 58 (43) 33 (36) 66 (49)
Other 1 (1) 12 (9) 1 (1) 17 (13)
Missing 1 (1) 2 (1) 4 (4) 5 (4)
Marital status, n (%)
Married/living together 13 (15) 109 (81) 22 (24) 103 (77)
Single/divorced/widowed/separated 72 (84) 24 (18) 65 (71) 29 (22)
Missing 1 (1) 1 (1) 5 (5) 2 (1)
Patient living with caregiver, n (%) 57 (66) 65 (71)
Patient face-to-face contact with carer per week, h: n (%)
0–7 24 (28) 23 (25)
8–14 14 (16) 8 (9)
15–21 5 (6) 8 (9)
>21 41 (48) 44 (48)
Other/missing 2 (2) 9 (10)
More than one caregiver involved, n (%) 44 (51) 39 (42)
Clinical characteristics
In-patient:day-patient service 78:8 84:8
Adolescent:adult service 6:80 5:87
Length of index admission, days: median (range) 148 (28–991) 163 (33–570)
Age at onset, years: median (range) 15 (5–45) 16 (6–41)
Duration of illness, months: median (range) 72 (12–456) 78 (9–480)
Lowest BMI since onset, mean (SD) 12.99 (1.71) 12.83 (1.88)
Previous hospital admissions, n (%)
0 25 (29) 33 (36)
1 15 (17) 24 (26)
2 12 (14) 7 (8)
3 7 (8) 2 (2)
4 3 (3) 4 (4)
≥5 9 (10) 5 (5)
Missing 15 (17) 17 (19)
Currently receiving medication, n (%) 13 (15) 19 (21)
Comorbidity, n (%)
None 24 (28) 33 (36)
Depression 45 (52) 36 (39)
Anxiety 0 (0) 2 (2)
Obsessive–compulsive disorder 7 (8) 9 (10)
Borderline 0 (0) 1 (1)
Missing 10 (12) 11 (12)
Caregiver eating disorder, n (%) 31 (23) 19 (14)
Family eating problems, n (%) 39 (29) 24 (18)
BMI, body mass index.
Hibbs et al
60
Downloaded from https://www.cambridge.org/core. 05 Nov 2020 at 16:56:45, subject to the Cambridge Core terms of use.
Service characteristics. Only 11 patients were recruited from
adolescent units and 16 from day-patient units. As expected, the
numbers were equally distributed between trial arms. It is
noteworthy that the adolescent units delivered family-based
therapy before, during and after the in-patient admission (88.9%
of caregivers of patients admitted to hospital at an adolescent in-
patient service attended family therapy during hospitalisation,
compared with 24.1% of caregivers of patients admitted to
hospital to an adult service).
Intervention adherence. Ninety-one caregivers (68% of ECHO
arm (15% missing information)) completed 75% of the coaching
sessions and the manual.
Important harms or unintended effects
Two patients (one from each trial arm) died during the course of
the study.
Outcomes
Fifty (28%) patients at discharge, 57 (32%) at 6-month post-
discharge and 66 (37%) at 12 months had missing questionnaire
outcome data. The number of caregivers with missing data was
86 (32%) at discharge, 98 (37%) at 6 months and 111 (41%) at
12 months. Service use data (structured interview) were missing
from 53 (30%) of patients at 6 months and 55 (31%) at 12 months.
Logistic regression was used to explore the relationships
between a dependent variable that represented whether outcome
data were present or missing at 12-month post-discharge and a
number of baseline demographic and clinical variables, such as
participant gender and lowest ever BMI, and also (post-treatment)
adherence to ECHO. Any variable that showed a statistically
significant association with the dependent variable was included in
the imputation step of the MI procedure. Lowest ever BMI was
predictive of missingness for patients’ quality of life, eating
disorder psychopathology (EDE-Q) and distress (DASS-21); age
predicted missingness for patients’ distress. It was also found that
non-adherence with allocated therapy was strongly associated with
missingness. The associations for caregivers (P-values as low as
P<0.001) were stronger than for patients (e.g. P=0.04).
Table 2 summarises the clinical outcomes and Table 3
provides estimated outcome differences between the two treat-
ment arms for both patients and caregivers at all three time points.
A comparison of patient clinical status in the year after
hospitalisation between caregivers with and without
ECHO intervention
Eating disorder psychopathology (EDE-Q) and quality of life
(WHO-Quol) were significantly better in the ECHO group at
6 months effect size (ES)=−0.38 and 0.38 respectively, but these
differences were not significant at 12-month post-discharge
(Table 3). At 6 months after discharge we found eating disorder
psychopathology (EDE-Q) among the ECHO group to be 0.47
points (95% CI 0.03–0.92) less than in the TAU group. At the
same time point, we estimated quality of life as measured on
the WHO-Quol to be 0.91 points (95% CI 0.04–1.78) higher in the
ECHO group compared with the TAU group. Estimated differ-
ences in distress and BMI pointed towards a beneficial effect of
ECHO, but none of these effects could be shown to be statistically
significant.
A comparison of caregivers’ well-being and burden in
the year after hospitalisation between caregivers with
and without ECHO intervention
Although caregivers in the ECHO group reported fewer symptoms
of distress than those in TAU, this was not statistically significant
at any time point (Table 3). Caregiving burden (EDSIS), at
discharge, was significantly lower in the ECHO group (ES=−0.29).
Time spent caregiving (ES=−0.34) and expressed emotion
(FQ, ES=−0.25) were significantly lower in the ECHO group at
6 months after discharge. At discharge, we estimated that
caregivers’ perceptions of eating disorder burden (EDSIS) in the
ECHO group were 3.98 points (95% CI 0.16–7.80) less compared
with TAU. At 6 months after discharge we found that time spent
caregiving in the ECHO group was 63% (95% CI 40–100) of that
spent in the TAU group. At the same time point, we estimated
expressed emotion (FQ) in the ECHO group to be 2.24 points
(95% CI 0.05–4.43) less on the FQ than in the TAU group. At 12
months, the difference between groups in terms of expressed
emotion, accommodating and caregiving time was negligible and
there was a small effect in favour of ECHO for mood, burden and
quality of life.
A comparison of patient service use between
caregivers with and without ECHO intervention
The ECHO group had a slightly shorter median duration of
admission (median=148 days, range 28–991) compared with the
TAU group (median=163 days, range 33–570) but this was not
statistically significant (Mann–Whitney U-test, Z=−0.88, P=0.38).
The readmission rate was 27% (n=23) in the ECHO group and 32%
(n=29) in the TAU group. Relapse in terms of readmission and/or
fall in two BMI points occurred in 43% of the ECHO group and
52% of TAU. The median time to relapse for the ECHO group was
262 days and 240 days for TAU. Survival plots of the time to
relapse showed two survival curves that were broadly similar.
A box and whisker plot in Fig. 2 depicts use of beds in the two
conditions in the year post-discharge. In the TAU condition, there
was a higher bed usage 7–12 months post-discharge than in the
ECHO group (Mann–Whitney U-test, Z=−1.97, P=0.049).
The summary of bed days, primary care and secondary care
appointments in the 6-month and 12-month intervals following
discharge are shown in Table 4. There was little difference
between the groups in terms of usage of primary and secondary
care. Only a small proportion of the sessions in both groups
involved the family.
Discussion
The aim of this study was to evaluate whether giving caregivers a
skills training intervention (ECHO) improved both patient and
caregiver outcomes in the year following hospital admission. All
patients fulfilled the World Health Organization’s definition of
severe malnutrition34 (and the majority had an illness duration of
more than 3 years). Patients whose caregivers received the ECHO
intervention had reduced eating disorder psychopathology (EDE-
Q) and improved quality of life (WHO-Quol) at 6 months (both
small effects) and reduced in-patient bed days (7–12 months post-
discharge). Estimated differences in distress and BMI pointed
towards a beneficial effect of ECHO, but none of these effects
could be shown to be statistically significant. Caregivers in the
ECHO group had a small/moderate reduction in caregiver burden
and reduced expressed emotion and a greater reduction in their
time caregiving 6 months after discharge but these changes were
diminished at 12 months. We did not find statistically significant
effects of ECHO in terms of our distal primary outcomes, patient
relapse and caregiver distress, although differences were in the
anticipated direction. The size of the change effects for all
secondary outcomes for both caregiver and patient were small
but all favoured ECHO. Fewer bed days were used in the ECHO
group.
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The impact of the intervention on caregiver outcomes was
limited to the first 6 months after discharge. This suggests that
further booster sessions of family skills training throughout the
year following admission or joint caregiver/patient sessions may
be needed. It is noteworthy that the reduced bed use is not at the
cost of greater burden and time caregiving from caregivers. Indeed
the opposite effect occurred.
Interestingly, the size of the effect in terms of improvement of
patient symptomatology remained present at 1 year suggesting
that the indirect impact on patients may be more sustained despite
less in-patient use. A 2-year follow-up of these patients that is in
progress will be of interest to validate this conclusion.
The qualitative feedback (previously reported) also indicates
that both patient and caregiver found the intervention helpful.35
Patients reported changes in their caregivers that include a greater
understanding and awareness of the illness and improved coping
abilities, better communication and reduced anxiety. Caregivers
themselves noted improvements in their caregiving skills.
Strengths
This study used the strengths of a pragmatic randomised
controlled design set within the majority of specialised eating
disorder centres in England and so is relevant to current NHS
England practice. This is one of the largest RCT studies within
an in-patient setting and unique in considering the caregiver
perspective. We added the intervention to TAU for pragmatic and
economic reasons. We obtained information from three sources,
patients, caregivers and services. The intervention was designed to
be easy to disseminate and uses many principles advocated for a
global application.36 As such, we used ‘task sharing’ with people
with lived experience as we had found this expertise valued in our
pilot studies. A small proportion of postgraduate psychologists were
trained to increase the capacity to deliver the intervention. In a
previously reported study, we found satisfactory levels of treatment
fidelity in both groups with these different background experiences.21
Thus, given the low cost of the intervention, and the reduction in
bed use (cost £470/day) and the potential for easy scalability and
reach, we consider that this intervention is clinically relevant.
Limitations
Because of the research requirements (the agreement to involve
caregivers), the sample is not necessarily representative of the
intended target population. This might affect generalisability
although in practice, because these materials are delivered directly
to the caregiver, they could be part of standard information
offered to caregivers in order to fulfil in-patient quality stan-
dards.23 In hindsight, a more eating disorder-related specific
outcome such as caregiver burden or quality of life rather than
caregiver distress may be more appropriate as the primary
outcome for caregivers. Also in hindsight, the use of a binary/
time to event outcome ‘relapse’ such as our primary patient
outcome was not useful for this patient group most of whom
continue to meet diagnostic criteria at discharge. Other outcomes
such as number of bed days, quality of life, BMI and/or the level of
psychopathology would be clinically more meaningful.
Although there are standard quality criteria for in-patient
care, the treatment ethos does vary between services. For example,
some services involve caregivers more than others. We found that
very little family support was offered as part of aftercare (on
average 1 session per case). It is noteworthy that the adolescent
units delivered family-based therapy before, during and after the
in-patient admission.21 It is possible that this may have diluted the
effect for these 11 families or it may even been harmful if the
messages delivered were contradictory. Work is in progress to
examine this possibility. This variability within the TAU condition
may have decreased the size of group effect but there would be no
bias in its estimation as the trial design was stratified by site.
Further work to examine the factors that may influence the overall
outcome will be of interest.
Clinical implications
A low-intensity skills-sharing intervention for the caregivers of
patients with anorexia nervosa admitted for hospital care pro-
duced a small decrease in caregiver burden, expressed emotion
and time spent caregiving at 6-month post-discharge but with less
of an effect later. There was a small but sustained improvement in
in-patients’ quality of life and clinical symptoms. In-patient bed
use 6–12 months after admission was reduced. This study
illustrates how involving the family during in-patient care for
adults as well as children can have benefits for both patient and
caregiver. However, this form of augmentation of skills sharing for
caregivers probably needs to be continued during the aftercare
maintenance phase, particularly as caregivers may be the primary
source of support for the individual during this time. The
intervention has the potential to be easily disseminated and there
may be a synergy in combining this with a skills-based intervention
for patients themselves. Further work investigating the optimisation
250
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Fig. 2 Box and whisker plot (medians, 75 centile and outliers) for
amount of time beds that were occupied in the year following
discharge. TAU, treatment as usual.
Table 4 Eating disorder-related service use at 6-month and
12-month follow-up post-discharge by treatment group (ECHO
experienced carer helping others v. TAU)
Eating disorder-related service use ECHO TAU Total
In-patient, days
6 months N=124 927 1276 2203
12 months N=120 499 1495 1994
GP/practise nurse, visits
6 months N=124 556 653 1209
12 months N=123 541 550 1092
Out-patient clinic, visits
6 months N=123 739 679 1418
12 months N=119 459 391 850
FBT/outreach/family support worker, visits
6 months N=124 33 115 148
12 months N=120 85 76 161
TAU, treatment as usual; GP, general practice; FBT, family-based therapy.
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of in-patient care and after care for people with severe enduring
anorexia nervosa is needed. It is noteworthy that in current NHS
practice, in-patient care is a palliative intervention, only partially
restoring weight. Although on average, the treatment gains are
maintained in the year post-discharge, most patients remain
severely ill. This poor outcome and the two deaths within the
study highlight the need for better treatment for this patient group.
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